Nyxoah S.A. (EBR:NYXH)
Belgium
· Delayed Price · Currency is EUR 9.92
-0.08 (-0.80%)
Feb 21, 2025, 9:00 AM CET
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €371.28 million as of February 21, 2025. Its market cap has increased by 18.25% in one year.
Market Cap
371.28M
Enterprise Value
323.63M
Revenue
5.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
€9.92
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 371.28M, a decrease of -11.13%. That is a compound annual growth rate of -2.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 371.28M | 20.10% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | 348.77M | -16.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 37.59B |
| UCB SA | 34.15B |
| Financière de Tubize | 6.38B |
| Fagron NV | 1.47B |
| Ion Beam Applications | 407.37M |
| Onward Medical | 260.63M |
| Hyloris Pharmaceuticals | 148.40M |
| Sequana Medical NV | 84.65M |